| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 885 | 2021 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 439 | 2021 |
| Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled … F Ader, M Bouscambert-Duchamp, M Hites, N Peiffer-Smadja, J Poissy, ... The Lancet infectious diseases 22 (2), 209-221, 2022 | 345 | 2022 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 329 | 2021 |
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 275 | 2021 |
| Is COVID‐19 infection more severe in kidney transplant recipients? S Caillard, N Chavarot, H Francois, M Matignon, C Greze, N Kamar, ... American Journal of Transplantation 21 (3), 1295-1303, 2021 | 236 | 2021 |
| Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth L Sentilhes, F De Marcillac, C Jouffrieau, P Kuhn, V Thuet, Y Hansmann, ... American journal of obstetrics and gynecology 223 (6), 914. e1-914. e15, 2020 | 223 | 2020 |
| Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020 C Kaeuffer, C Le Hyaric, T Fabacher, J Mootien, B Dervieux, Y Ruch, ... Eurosurveillance 25 (48), 2000895, 2020 | 138 | 2020 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 128 | 2022 |
| CT lung lesions as predictors of early death or ICU admission in COVID-19 patients Y Ruch, C Kaeuffer, M Ohana, A Labani, T Fabacher, P Bilbault, S Kepka, ... Clinical Microbiology and Infection 26 (10), 1417. e5-1417. e8, 2020 | 93 | 2020 |
| Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort R Carapito, R Li, J Helms, C Carapito, S Gujja, V Rolli, R Guimaraes, ... Science translational medicine 14 (628), eabj7521, 2022 | 85 | 2022 |
| Portraying infective endocarditis: results of multinational ID-IRI study H Erdem, E Puca, Y Ruch, L Santos, N Ghanem-Zoubi, X Argemi, ... European Journal of Clinical Microbiology & Infectious Diseases 38, 1753-1763, 2019 | 47 | 2019 |
| SARS‐CoV‐2 viral load in nasopharyngeal swabs in the emergency department does not predict COVID‐19 severity and mortality P Le Borgne, M Solis, F Severac, H Merdji, Y Ruch, K Alamé Intern, ... Academic Emergency Medicine 28 (3), 306-313, 2021 | 40 | 2021 |
| Impact of setting up an “endocarditis team” on the management of infective endocarditis Y Ruch, JP Mazzucotelli, F Lefebvre, A Martin, N Lefebvre, N Douiri, ... Open Forum Infectious Diseases 6 (9), ofz308, 2019 | 37 | 2019 |
| Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial X Mariette, O Hermine, PL Tharaux, M Resche-Rigon, R Porcher, ... The Lancet Rheumatology 4 (1), e24-e32, 2022 | 36 | 2022 |
| Managing adult patients with infectious diseases in emergency departments: international ID-IRI study H Erdem, S Hargreaves, H Ankarali, H Caskurlu, SA Ceviker, ... Journal of Chemotherapy 33 (5), 302-318, 2021 | 29 | 2021 |
| The COVID-19 vaccination acceptance/hesitancy rate and its determinants among healthcare workers of 91 Countries: A multicenter cross-sectional study M Askarian, A Semenov, F Llopis, F Rubulotta, G Dragovac, ... EXCLI journal 21, 93, 2022 | 26 | 2022 |
| Left ventricular assist device-associated infections: incidence and risk factors A Rahal, Y Ruch, N Meyer, S Perrier, TH Minh, C Schneider, T Lavigne, ... Journal of Thoracic Disease 12 (5), 2654, 2020 | 23 | 2020 |
| Corticosteroids in patients hospitalized for COVID-19 pneumonia who require oxygen: observational comparative study using routine care data VT Tran, M Mahévas, F Bani-Sadr, O Robineau, T Perpoint, E Perrodeau, ... Clinical Microbiology and Infection 27 (4), 603-610, 2021 | 21 | 2021 |
| Vector-borne and zoonotic infections and their relationships with regional and socioeconomic statuses: An ID-IRI survey in 24 countries of Europe, Africa and Asia FN Saydam, H Erdem, H Ankarali, MEEA Ramadan, NM El-Sayed, ... Travel medicine and infectious disease 44, 102174, 2021 | 16 | 2021 |
